Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study
| Autor: | Antonia, Scott, Goldberg, Sarah B, Balmanoukian, Ani, Chaft, Jamie E, Sanborn, Rachel E, Gupta, Ashok, Narwal, Rajesh, Steele, Keith, Gu, Yu, Karakunnel, Joyson J, Rizvi, Naiyer A * |
|---|---|
| Zdroj: | In The Lancet Oncology March 2016 17(3):299-308 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|